Quest Diagnostics Integrated (NYSE: DGX), a supplier of diagnostic data providers, has reaffirmed its outlook for fiscal 2025 and supplied cautious first-quarter steering.
- Quest stated it continues to anticipate full-year 2025 web income to be within the vary of $10.70 billion to $10.85 billion
- The steering represents an 8.4% to $9.9% enhance in full-year web income
- The corporate reaffirmed its earnings per share steering for FY25, on a reported foundation, within the $8.34-$8.59 vary
- Adjusted earnings per share are anticipated to be between $9.55 and $9.80 within the fiscal 12 months, which is in step with the earlier steering
- The administration continues to anticipate money supplied by operations to be roughly $1.45 billion in FY25, and capital expenditure to be $500 million
- For the primary quarter of 2025, the corporate expects the worse-than-anticipated climate to create a headwind to income of round $25 million, and to EPS of about $0.10
